Primary hyperparathyroidism (PHPT) refers to the dysregulation of calcium-PTH
homeostasis due to an abnormality at the parathyroid glands–namely due to an adenoma or …

Introduction Traditional parathyroid registries are labor-intensive and do not always capture
long-term follow-up data. This study aimed to develop a patient-driven international …

Background Interest in microwave ablation (MWA) and radiofrequency ablation (RFA) use
for treating secondary hyperparathyroidism (SHPT) is rising; however, ablation outcomes in …

Objective: Hyperparathyroidism (HPT) is nearly universal in patients with end-stage kidney
disease. Kidney transplantation (KT) reverses HPT in many patients, but most studies have …

Background Hyperparathyroidism is common in patients with end‐stage kidney disease and
may persist after kidney transplantation (KT). Parathyroidectomy (PTx) is curative, but …

Background Hyperparathyroidism (HPT) and malignancy are the most common causes of
hypercalcemia. Among kidney transplant (KT) recipients, hypercalcemia is mostly caused by …

Background Racial disparities in care exist for diseases with heterogeneous treatment
guidelines. The impact of these disparities on outcomes after parathyroidectomy for …

摘要随着透析患者的持续增加及透析时间增长, 慢性肾脏病(CKD) 相关的继发性甲状旁腺功能
亢进(SHPT) 发病率持续增加, 需要外科干预的患者人数也随之增加. 美国内分泌外科医师协会 …

Background Parathyroid carcinoma and parathyromatosis are very rare diseases in patients
on hemodialysis. Its pathogenesis, clinical features, preoperative diagnosis, and surgery are …

Background: Surgery for irreversible hyperparathyroidism is the preferred management for
kidney transplant patients. The authors analyzed the factors associated with persistent …